Alzheimer’s Disease/Dementia News

Intranasal insulin treatment over a 12-month period failed to provide cognitive or functional benefits to older adults with amnestic mild cognitive impairment or Alzheimer’s disease, according to a study published in JAMA Neurology.

The combination of several healthy lifestyle behaviors appeared to significantly reduce risk for Alzheimer’s dementia, according to results of two longitudinal studies published in Neurology.

Clinicians should use caution when prescribing antipsychotics and benzodiazepines to treat patients with dementia because of an apparent increased risk for death, according to a study published in Journal of Clinical Psychiatry.

Aerobic exercise appeared to reduce cognitive impairment — a finding that may help guide future Alzheimer’s disease research, according to study results published in Journal of Alzheimer’s Disease.

Administering the Montreal Cognitive Assessment, or MoCA, via telehealth poses challenges, one of the tool’s developers told Healio Primary Care.

Healio and Cardiology Today present a list of the top read news in psychiatry and CV health.

The FDA recently announced the approval of Tauvid, an IV injection that is used to help image a specific characteristic of Alzheimer’s disease in the brain known as tau pathology.

Patients taking antihypertensive medications had lower risk for incident dementia or cognitive impairment compared with control groups, according to a systematic review and meta-analysis published in JAMA.

A series of review articles found limited or inconsistent data supporting the accuracy of biomarkers and cognitive tests for diagnosing and differentiating Alzheimer’s disease, as well as drug treatments that minimally impacted functional decline.

The Mental Health America organization has designated each May as Mental Health Awareness Month.